Literature DB >> 31818532

2016-2017 Arkansas mumps outbreak in a close-knit community: Assessment of the economic impact and response strategies.

Jamison Pike1, Mona Marin2, Angela Guo2, Dirk Haselow3, Haytham Safi3, Fangjun Zhou2.   

Abstract

On August 8, 2016, a confirmed case of mumps was reported to the Arkansas Department of Health (ADH) in an adult resident of Springdale, Arkansas. By July 2017, nearly 3,000 cases of mumps were reported to ADH from 37 of the 75 counties in Arkansas. Over 50% of cases were in the Arkansas Marshallese community, a close-knit community characterized by large, and extended families sharing the same living space and communal activities. In a statewide effort, ADH collaborated with CDC, the Republic of the Marshall Island's (RMI) Ministry of Health, and the Arkansas Department of Education (ADE) to rapidly respond to and contain the outbreak. We assessed the economic burden to ADH of the outbreak response in terms of containment and vaccination costs, as well as response costs incurred by CDC, RMI, and ADE. The 2016-2017 Arkansas mumps outbreak was the second largest US mumps outbreak in over 30 years and was unique in size, spread, and population affected. Total public health response costs as a result of the outbreak were over $2.1 million, approximately $725 per case. The costs incurred to control this outbreak reflect the response strategies tailored to the affected populations, including consideration of social, cultural, and political factors in controlling transmission and requirements of distinctive strategies for public health outreach. Aside from the burden these outbreaks have on the affected population, we demonstrate the potential for high economic burden of these outbreaks to public health. Published by Elsevier Ltd.

Entities:  

Keywords:  Arkansas Marshallese; Cost of outbreak; Economic burden; Mumps

Mesh:

Year:  2019        PMID: 31818532      PMCID: PMC8963766          DOI: 10.1016/j.vaccine.2019.11.066

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.

Authors:  Fangjun Zhou; Susan Reef; Mehran Massoudi; Mark J Papania; Hussain R Yusuf; Barbara Bardenheier; Laura Zimmerman; Mary M McCauley
Journal:  J Infect Dis       Date:  2004-05-01       Impact factor: 5.226

2.  Cost of Responding to the 2017 University of Washington Mumps Outbreak: A Prospective Analysis.

Authors:  Jamison Pike; Sheryl Schwartz; Meagan Kay; Ailyn Perez-Osorio; Mona Marin; Mark Jenkins; Janell Routh; Jeff Duchin; Chas DeBolt; Fangjun Zhou
Journal:  J Public Health Manag Pract       Date:  2020 Mar/Apr

3.  Neocolonialism and Health Care Access among Marshall Islanders in the United States.

Authors:  Michael R Duke
Journal:  Med Anthropol Q       Date:  2017-05-24

4.  Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010.

Authors:  Preeta Krishnan Kutty; Jacqueline Lawler; Elizabeth Rausch-Phung; Ismael R Ortega-Sanchez; Stephen Goodell; Cynthia Schulte; Lynn Pollock; Barbara Valure; Jean Hudson; Kathleen Gallagher; Debra Blog
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

5.  Measles prevention.

Authors: 
Journal:  MMWR Suppl       Date:  1989-12-29

6.  Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report.

Authors:  Virgie S Fields; Haytham Safi; Catherine Waters; Jennifer Dillaha; Lucy Capelle; Sheldon Riklon; J Gary Wheeler; Dirk T Haselow
Journal:  Lancet Infect Dis       Date:  2019-01-08       Impact factor: 25.071

7.  Economic impact of the 2009-2010 Guam mumps outbreak on the public health sector and affected families.

Authors:  Abdirahman Mahamud; A Parker Fiebelkorn; George Nelson; Annette Aguon; John McKenna; Gissela Villarruel; Kathleen Gallagher; Ismael R Ortega-Sánchez
Journal:  Vaccine       Date:  2012-08-14       Impact factor: 3.641

8.  Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Huong Q McLean; Amy Parker Fiebelkorn; Jonathan L Temte; Gregory S Wallace
Journal:  MMWR Recomm Rep       Date:  2013-06-14

9.  Economic evaluation of the routine childhood immunization program in the United States, 2009.

Authors:  Fangjun Zhou; Abigail Shefer; Jay Wenger; Mark Messonnier; Li Yan Wang; Adriana Lopez; Matthew Moore; Trudy V Murphy; Margaret Cortese; Lance Rodewald
Journal:  Pediatrics       Date:  2014-03-03       Impact factor: 7.124

10.  Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak.

Authors:  Mona Marin; Mariel Marlow; Kelly L Moore; Manisha Patel
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-12       Impact factor: 17.586

View more
  3 in total

1.  Societal Costs of a Measles Outbreak.

Authors:  Jamison Pike; Alan Melnick; Paul A Gastañaduy; Meagan Kay; Jeff Harbison; Andrew J Leidner; Samantha Rice; Kennly Asato; Linda Schwartz; Chas DeBolt
Journal:  Pediatrics       Date:  2021-03-12       Impact factor: 7.124

2.  Forecasting the incidence of mumps in Chongqing based on a SARIMA model.

Authors:  Hongfang Qiu; Han Zhao; Haiyan Xiang; Rong Ou; Jing Yi; Ling Hu; Hua Zhu; Mengliang Ye
Journal:  BMC Public Health       Date:  2021-02-17       Impact factor: 3.295

3.  A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks.

Authors:  Janetta E Skarp; Laura E Downey; Julius W E Ohrnberger; Lucia Cilloni; Alexandra B Hogan; Abagael L Sykes; Susannah S Wang; Hiral Anil Shah; Mimi Xiao; Katharina Hauck
Journal:  Appl Health Econ Health Policy       Date:  2021-06-11       Impact factor: 3.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.